Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в травні 1996 (uk)
- im Mai 1996 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en mayu de 1996 (ast)
- scientific article published on 01 May 1996 (en)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - D M Finkelstein
- J Feinberg
- S Safrin
- A Wu
- R Soeiro
- J R Black
- G Simpson
- T Cheung
- P Frame
- P Hojczyk
|
rdfs:label
| - Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 (en)
- Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 (nl)
|
skos:prefLabel
| - Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 (en)
- Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 (nl)
|
name
| - Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 (en)
- Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 (nl)
|
title
| |
title
| - Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.7326/0003-4819-124-9-199605010-00003
|
is about
of | |
is cites work
of | - Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death
- Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America
- Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial
- The importance of health-related quality-of-life data in determining the value of drug therapy
- Treatment of infection due to Pneumocystis carinii
- The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections
- Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).
- A young man with myelosuppression caused by clindamycin: a case report
- A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials
- Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.
- Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management
- Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
- Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi
- Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers
- The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
- Staphylococcal skin infections in children: rational drug therapy recommendations
- Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy
- Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis.
- Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.
- Antiprotozoal drugs
- Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions
- Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study
- A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole
- Current indications for the use of clindamycin: A critical review
- Pneumocystis jirovecii colonization in Chronic Obstructive Pulmonary Disease (COPD).
- Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the
- Dapsone-Induced Acute Pancreatitis
- Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia
- Quantitative structure-activity relationship studies of a series of sulfa drugs as inhibitors of Pneumocystis carinii dihydropteroate synthetase
- Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy
- Low-Dose TMP-SMX in the Treatment of Pneumocystis jirovecii Pneumonia: A Systematic Review and Meta-analysis
- Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients
- HIV: treating Pneumocystis pneumonia (PCP)
- Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
- Pneumonia in AIDS patients in the critical care unit
- Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients.
- Antimicrobial agents.
- Prevention of adverse events in hospitalized patients using an antimicrobial review program
- The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients
- Apical Pneumocystis jiroveci as an AIDS defining illness: A case report illustrating a change in the paradigm
|
is cites work
of | |